MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
The project is part of a three-year-long partnership between Honeywell and Americares to strengthen the health infrastructure in rural Maharashtra, Uttarakhand and Haryana
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
Themis will market this drug with the brand name REMITHEM.
Subscribe To Our Newsletter & Stay Updated
